Added to YB: 2024-01-05
Pitch date: 2024-01-05
MREO [bullish]
Mereo BioPharma Group plc
-13.2%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
Market Cap
$281.6M
Pitch Price
$2.50
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.22
P/E
-5.60
EV/Sales
452.15
Sector
Biotechnology
Category
special_situation
$MREO: Activist believes their plan is going well
$MREO: Activist Rubric Capital's plan to unlock sum-of-parts value progressing slowly but surely. Positive Ph2 osteogenesis imperfecta data w/$RARE & Rubric's continued buying suggest thesis is on track despite lack of public updates. Promising signs but still early days.
Read full article (1 min)